These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1328134)

  • 1. Effects of itraconazole on phagocytosis and killing of Candida glabrata by polymorphonuclear leucocytes from guinea pigs.
    Xhonneux B; Jansen T; Borgers M; Odds FC
    J Antimicrob Chemother; 1992 Aug; 30(2):181-8. PubMed ID: 1328134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-vitro effect of itraconazole, ketoconazole and amphotericin B on the phagocytic and candidacidal function of human neutrophils.
    Johnson EM; Warnock DW; Richardson MD; Douglas CJ
    J Antimicrob Chemother; 1986 Jul; 18(1):83-91. PubMed ID: 3019981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of azole antifungals in vitro on host/parasite interactions relevant to Candida infections.
    Odds FC; Webster CE
    J Antimicrob Chemother; 1988 Oct; 22(4):473-81. PubMed ID: 2849601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro effects of cilofungin (LY121019), amphotericin B and amphotericin B-deoxycholate on human polymorphonuclear leucocytes.
    Van der Auwera P; Meunier F
    J Antimicrob Chemother; 1989 Nov; 24(5):747-63. PubMed ID: 2557318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activity of amphotericin B and intraconazole against intraphagocytic Candida albicans.
    Ponce E; Pechère JC
    Eur J Clin Microbiol Infect Dis; 1990 Oct; 9(10):738-44. PubMed ID: 2175704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [In vitro investigations of Candida strains for itraconazole].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(1):23-7. PubMed ID: 2554367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of Candida albicans yeast cells, germ tubes and hyphae with human polymorphonuclear leucocytes in vitro.
    Cockayne A; Odds FC
    J Gen Microbiol; 1984 Mar; 130(3):465-71. PubMed ID: 6327882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparison of the susceptibility of Candida strains to ketoconazole and itraconazole in in vitro experiments].
    Gwieździński Z; Nierebińska E; Urbanowski S
    Przegl Dermatol; 1989; 76(5-6):399-404. PubMed ID: 2561924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative sensitivity of yeasts to ketoconazole, itraconazole and fluconazole using a liquid medium standardized micromethod].
    Guinet R; Marlier H
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):575-8. PubMed ID: 2166937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Candida activity of azoles].
    Van Cutsem J; Van Gerven F; Janssen PA
    Ann Biol Clin (Paris); 1987; 45(6):661-8. PubMed ID: 2830810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modification of polymorphonuclear leucocyte function by imidazoles.
    Rowan-Kelly B; Ferrante A; Thong YH
    Int J Immunopharmacol; 1984; 6(4):389-93. PubMed ID: 6090323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of fluconazole and itraconazole on human polymorphonuclear leukocyte oxidative metabolism and phagocytosis].
    Velert MM; Cabrera E; Orero A; Pemán J; Cantón E
    Rev Esp Quimioter; 1998 Mar; 11(1):70-4. PubMed ID: 9795293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergy of itraconazole with macrophages in killing Blastomyces dermatitidis.
    Brummer E; Bhagavathula PR; Hanson LH; Stevens DA
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2487-92. PubMed ID: 1336949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antifungal activity of itraconazole and ketoconazole investigated in vitro, determined with minimal inhibitory concentrations and mycelial cell transformation in Candida albicans].
    Urbanowski S; Nierebińska E; Gwieździński Z
    Przegl Dermatol; 1989; 76(5-6):405-9. PubMed ID: 2561925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro effect of itraconazole against various species of Candida].
    Bastide M; Mallie M; Jouvert S; Montes B; Bastide JM
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):694-9. PubMed ID: 2552381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In-vitro and in-vivo activity of itraconazole].
    Van Cutsem J
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():5-8. PubMed ID: 1663204
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-Lipoxygenase inhibition by antifungal azole derivatives: new tools for immunosuppression?
    Jaschonek K; Steinhilber D; Einsele H; Ehninger G; Roth HJ
    Eicosanoids; 1989; 2(3):189-90. PubMed ID: 2560935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei.
    Drago M; Scaltrito MM; Morace G;
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):619-24. PubMed ID: 15258831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.